We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CNTX market cap is 60M. The company's latest EPS is USD -0.3195 and P/E is -2.54.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.18M | -6.93M | -3.82M | -3.09M | -18.7M |
| Net Income | -5.87M | -6.77M | -3.67M | -2.25M | -17.46M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -10.53M | -15.88M | -25.07M |
| Net Income | -10.46M | -15.34M | -23.96M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 22.99M | 16.06M | 11.05M | 102.71M | 86.33M |
| Total Liabilities | 4.6M | 4.19M | 2.61M | 1.61M | 2.47M |
| Total Equity | 18.39M | 11.87M | 8.44M | 101.1M | 83.86M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 51.31M | 37.97M | 16.06M |
| Total Liabilities | 3.03M | 3.21M | 4.19M |
| Total Equity | 48.27M | 34.76M | 11.87M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -13.82M | -21.05M | -4.36M | -7.72M | -9.65M |
| Investing | N/A | N/A | N/A | N/A | -14.76M |
| Financing | N/A | N/A | N/A | 94.8M | 94.76M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.8M | -13.55M | -21.05M |
| Investing | -250k | -537k | N/A |
| Financing | 58.39M | -102k | N/A |
| Market Cap | 60M |
| Price to Earnings Ratio | -2.54 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.2 |
| Price to Book Ratio | 5.12 |
| Dividend Yield | - |
| Shares Outstanding | 75M |
| Average Volume (1 week) | 56.54k |
| Average Volume (1 Month) | 118.95k |
| 52 Week Change | -27.27% |
| 52 Week High | 2.75 |
| 52 Week Low | 0.77 |
| Spread (Intraday) | 0.47 (38.52%) |
| Company Name | Context Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.contexttherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
